Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.
about
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.Idiopathic thrombotic thrombocytopenic purpura: strongest risk factor for relapse from remission is having had a relapse.Thrombosis and von Willebrand Factor.Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice.
P2860
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Measurement and prevalence of ...... otic thrombocytopenic purpura.
@ast
Measurement and prevalence of ...... otic thrombocytopenic purpura.
@en
type
label
Measurement and prevalence of ...... otic thrombocytopenic purpura.
@ast
Measurement and prevalence of ...... otic thrombocytopenic purpura.
@en
prefLabel
Measurement and prevalence of ...... otic thrombocytopenic purpura.
@ast
Measurement and prevalence of ...... otic thrombocytopenic purpura.
@en
P2093
P2860
P50
P356
P1476
Measurement and prevalence of ...... botic thrombocytopenic purpura
@en
P2093
P2860
P304
P356
10.1111/JTH.12494
P577
2014-01-01T00:00:00Z